AC
Armistice Capital Portfolio holdings
AUM
$2.64B
1-Year Return
0.99%
This Quarter Return
+4.82%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$1.16B
AUM Growth
+$78.3M
(+7.2%)
Cap. Flow
+$41.1M
Cap. Flow
% of AUM
3.54%
Top 10 Holdings %
Top 10 Hldgs %
38.88%
Holding
90
New
27
Increased
21
Reduced
13
Closed
22
Top Buys
| 1 |
Edgewell Personal Care
EPC
|
$55.1M |
| 2 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$44.8M |
| 3 |
J.M. Smucker
SJM
|
$34.8M |
| 4 |
Incyte
INCY
|
$28.7M |
| 5 |
Theravance Biopharma
TBPH
|
$26.8M |
Top Sells
| 1 |
United Therapeutics
UTHR
|
$43.6M |
| 2 |
Freshpet
FRPT
|
$39.7M |
| 3 |
Cheesecake Factory
CAKE
|
$33.8M |
| 4 |
Post Holdings
POST
|
$29.7M |
| 5 |
Assertio
ASRT
|
$28M |
Sector Composition
| 1 | Healthcare | 49.93% |
| 2 | Consumer Discretionary | 30.9% |
| 3 | Consumer Staples | 11.38% |
| 4 | Communication Services | 0.98% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Larimar Therapeutics
LRMR
$337M
| $15.3M | 1% |
125,000
+50,000
| +67% | +$6.14M |
|
27
Enanta Pharmaceuticals
ENTA
$189M
| $14.4M | 0.94% |
124,000
-8,000
| -6% | -$927K |
|
|
ALXN
28
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $13.9M | 0.91% |
+112,000
| New | +$13.9M |
|
|
CELG
29
DELISTED
Celgene Corp
CELG
| $13.9M | 0.91% |
+175,000
| New | +$13.9M |
|
|
APRN
30
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
| $13.4M | 0.88% |
22,222
+309
| +1% | +$186K |
|
|
SBBP
31
DELISTED
Strongbridge Biopharma plc.
SBBP
| $12.9M | 0.85% |
2,158,000
-1,214,000
| -36% | -$7.28M |
|
32
Papa John's
PZZA
$1.58B
| $12.7M | 0.83% |
+250,000
| New | +$12.7M |
|
|
DFRG
33
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
| $12.6M | 0.82% |
+1,000,000
| New | +$12.6M |
|
|
ONCE
34
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $12.4M | 0.81% |
150,000
-30,000
| -17% | -$2.48M |
|
|
PRTK
35
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $11.5M | 0.75% |
1,132,000
+552,000
| +95% | +$5.63M |
|
|
ACHN
36
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $11.3M | 0.74% |
4,000,000
-296,000
| -7% | -$838K |
|
37
Best Buy
BBY
$16.1B
| $10.4M | 0.68% |
+140,000
| New | +$10.4M |
|
|
QVCGA
38
QVC Group, Inc. Series A Common Stock
QVCGA
$73.3M
| $10.4M | 0.68% |
+10,094
| New | +$10.4M |
|
39
Cenntro
CENN
$26.7M
| $10.1M | 0.66% |
+107
| New | +$10.1M |
|
40
Alphatec Holdings
ATEC
$2.43B
| $9.63M | 0.63% |
3,230,414
+738,000
| +30% | +$2.2M |
|
41
Kiora Pharmaceuticals
KPRX
$9.2M
| $8.91M | 0.58% |
3,112
+2,891
| +1,308% | +$8.27M |
|
42
Voyager Therapeutics
VYGR
$235M
| $8.44M | 0.55% |
+432,000
| New | +$8.44M |
|
|
43
Assertio
ASRT
$76.8M
| $7.86M | 0.51% |
294,475
-1,049,275
| -78% | -$28M |
|
44
Yelp
YELP
$2.02B
| $7.84M | 0.51% |
+200,000
| New | +$7.84M |
|
45
CRISPR Therapeutics
CRSP
$4.99B
| $7.29M | 0.48% |
+124,000
| New | +$7.29M |
|
46
Designer Brands
DBI
$231M
| $7.23M | 0.47% |
+280,000
| New | +$7.23M |
|
|
NVLN
47
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
| $6.83M | 0.45% |
1,856,000
| – | – |
|
|
ALIM
48
DELISTED
Alimera Sciences, Inc.
ALIM
| $6.79M | 0.44% |
462,400
| – | – |
|
49
Solid Biosciences
SLDB
$428M
| $6.41M | 0.42% |
+12,000
| New | +$6.41M |
|
|
CMRX
50
DELISTED
Chimerix, Inc.
CMRX
| $5.99M | 0.39% |
1,258,000
+226,800
| +22% | +$1.08M |
|